Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 96 | 102 | 109 | 110 | 111 |
| Accounts payable and accrued liabilities | -5,281 | 4,690 | -3,625 | 3,235 | -690 |
| Other Working Capital | -3,521 | 1,089 | -3,078 | 2,501 | 223 |
| Other Operating Activity | -1,670 | -11,659 | -5,169 | -15,105 | -10,180 |
| Operating Cash Flow | $-10,376 | $-5,778 | $-11,763 | $-9,259 | $-10,536 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 17 | 1 | 0 | 0 |
| Other Investing Activity | 0 | 1,992 | -1,992 | 1,938 | 12,953 |
| Investing Cash Flow | $0 | $2,009 | $-1,991 | $1,938 | $12,953 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 0 | 4,931 | 11,829 | 844 | 4,894 |
| Other Financing Activity | 8 | -177 | 18 | 10 | 8 |
| Financing Cash Flow | $10,008 | $4,754 | $11,847 | $854 | $4,902 |
| Exchange Rate Effect | 0 | -1 | 1 | -1 | 1 |
| Beginning Cash Position | 8,330 | 7,346 | 9,252 | 15,720 | 8,400 |
| End Cash Position | 7,962 | 8,330 | 7,346 | 9,252 | 15,720 |
| Net Cash Flow | $-368 | $985 | $-1,907 | $-6,467 | $7,319 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,376 | -5,778 | -11,763 | -9,259 | -10,536 |
| Free Cash Flow | -10,376 | -5,778 | -11,763 | -9,259 | -10,536 |